![Nimish Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nimish Shah
Gründer bei
APOGEE THERAPEUTICS, INC.
Vermögen: - $ am 30.06.2026
Profil
Nimish P.
Shah is the founder of Apogee Therapeutics, Inc., founded in 2022, serving as Independent Director since 2023.
Current job includes Principal at Venrock Associates since 2013.
Former jobs include Director at Instil Bio, Inc. from 2020 to 2021, Research Analyst at Credit Suisse Securities (USA) LLC (Broker) from 2007 to 2010, Senior Consultant at Syneos Health Consulting, Inc. from 2006 to 2007, Associate at Novartis Pharmaceuticals Corp.
from 2002 to 2003, and Research Analyst at Surveyor Capital Ltd. from 2010 to 2013.
Education includes undergraduate degree from Rutgers State University of New Jersey in 2001, MBA from Columbia Business School, and graduate degree from Mailman School of Public Health.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.07.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Nimish Shah
| Unternehmen | Position | Beginn |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Gründer | 01.01.2022 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Private Equity Investor | 01.07.2013 |
Ehemalige bekannte Positionen von Nimish Shah
| Unternehmen | Position | Ende |
|---|---|---|
| INSTIL BIO, INC. | Direktor/Vorstandsmitglied | 17.12.2021 |
Surveyor Capital Ltd.
 Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Analyst-Equity | 01.06.2013 |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Syneos Health Consulting, Inc.
 Syneos Health Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical and biotech industries | Corporate Officer/Principal | - |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | - |
Ausbildung von Nimish Shah
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
95
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Credit Suisse Securities (USA) LLC (Broker)
Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Venrock Associates
Venrock Associates Investment ManagersFinance Venrock Associates invests in companies located in the US. The firm focuses on sectors such as intelligent enterprise & AI, security & infrastructure, fintech, healthcare IT, defense & Aerospace, robotics & autonomy and consumer sectors. It participates in early and later stage transactions. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syneos Health Consulting, Inc.
Syneos Health Consulting, Inc. Miscellaneous Commercial ServicesCommercial Services Provides consulting services to pharmaceutical and biotech industries | Commercial Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Surveyor Capital Ltd.
Surveyor Capital Ltd. Investment Trusts/Mutual FundsMiscellaneous Surveyor Capital is a global, multi-manager equities strategy and is one of Citadel’s three fundamental equities businesses. Their sector-aligned investment teams conduct deep fundamental research, developing an independent view on the companies they cover. They are specialists in their industries and experts in their coverage, building trusted relationships with many corporate management teams. The firm's investment teams leverage Citadel’s proprietary, market-neutral risk framework with the aim of building portfolios that minimize broad market exposures. Using this insight, they act on their investment theses and scale their risk-taking with confidence. | Miscellaneous |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mailman School of Public Health
 Mailman School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
